Nicholas Stones, Novartis Pharma AG - Qepler Summits And Conferences

Nicholas Stones

Senior Device Manager - Human Factors
Novartis Pharma AG
Basel, Switzerland
Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide.

Nick holds bachelors and masters degrees in engineering from the University of Oxford in the UK. Since 1998, he has worked in research, development and commercialization of drug delivery systems for various medical device and specialty Pharma companies in the UK, US and Switzerland. Nick joined Novartis in 2009 and was responsible for establishing the Human Factors Engineering process within device development. He has supported the development of several marketed products including the LUCENTIS® pre-filled syringe for intra-vitreal injection as well as the COSENTYX® Sensoready Pen for home use.

Nick works within the human factors team with a focus on HFE strategy, health authority communication, HFE process and platforming as well as the translation of user needs into design inputs.

Related Sessions:

2nd Annual Drug/Device
Combination Products Summit 2019

Get up to date with the regulatory and quality compliance strategies for combination product development.
  • 04 Dec 2019
  • Prague, CZ
  • Pharma
Day 2: Thursday, 05 December 2019
CASE STUDY: Can a “platform approach” support Human Factors activities?
  • What is a “platform approach”?
  • Opportunities of using a “platform approach” to support the Human Factors/Usability activities
  • Advantages of implementing a technology platform approach
  • Challenges / unknown when applying a platform approach for Human Factors
View Details
This website stores cookies on your computer. These cookies are used to collect information about how you interact with our website and allow us to remember you. We use this information in order to improve and customize your browsing experience and for analytics and metrics about our visitors both on this website and other media. To find out more about the cookies we use, see our Cookies Policy.